Search research articles
Contact Us
Filters
Showing results (271-280 of 467) with videos related to
Page
of 47
Sort By:
HIV Medicine
|
April 30, 2026
Effectiveness of switching regimen in people living with HIV and persistent low-level viraemia in the modern antiretroviral treatment era
Tommaso Clemente, Pierluigi Reali, Riccardo Lolatto, et al.
Open Forum Infectious Diseases
|
July 4, 2024
One Year of Long-Acting Cabotegravir and Rilpivirine in People With Human Immunodeficiency Virus and Long Exposure to Antiretroviral Therapy: Data From the SCohoLART Study
Camilla Muccini, Nicola Gianotti, Sara Diotallevi, et al.
Clinical Therapeutics
|
August 25, 2024
Combination of High-Dose Daptomycin and Ceftriaxone for Cardiac Implantable Electronic Device Infections: A 10-Year Experience
Giacomo Ponta, Martina Ranzenigo, Alessandra Marzi, et al.
The Journal of Antimicrobial Chemotherapy
|
February 3, 2012
Viral tropism by geno2pheno as a tool for predicting CD4 decrease in HIV-1-infected naive patients with high CD4 counts
Silvia Nozza, Filippo Canducci, Laura Galli, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 14, 2009
Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis
Antonella d'Arminio Monforte, Alessandro Cozzi-Lepri, Antonella Castagna, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
December 14, 2020
Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Adults With HIV and M184V/I Mutation
Ignacio Perez-Valero, Josep M Llibre, Antonella Castagna, et al.
Plants (Basel, Switzerland)
|
July 27, 2022
Foliar and Root Comparative Metabolomics and Phenolic Profiling of Micro-Tom Tomato (<i>Solanum lycopersicum</i> L.) Plants Associated with a Gene Expression Analysis in Response to Short Daily UV Treatments
Alessia Mannucci, Marco Santin, Lucas Vanhaelewyn, et al.
Plos One
|
August 2, 2017
Efficacy and safety of switching from branded to generic antiretrovirals in virologically suppressed HIV-infected patients
Nicola Gianotti, Andrea Poli, Laura Galli, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
August 16, 2022
Prevalence and Risk Factors of Anal HPV Infection in MSM Living With HIV: Identifying the Target Groups to Prioritize for Immunization
Elena Bruzzesi, Laura Galli, Andrea Poli, et al.
HIV Medicine
|
December 1, 2025
User-reported outcomes of long-acting injectable PrEP with Cabotegravir: Real-world experience from Milan
Angelo Roberto Raccagni, Flavia Passini, Riccardo Lolatto, et al.
Page
of 47
Search research articles
Search
Showing results (271-280 of 467) with videos related to
Sort By:
Page
of 47
HIV Medicine
|
April 30, 2026
Effectiveness of switching regimen in people living with HIV and persistent low-level viraemia in the modern antiretroviral treatment era
Tommaso Clemente, Pierluigi Reali, Riccardo Lolatto, et al.
Open Forum Infectious Diseases
|
July 4, 2024
One Year of Long-Acting Cabotegravir and Rilpivirine in People With Human Immunodeficiency Virus and Long Exposure to Antiretroviral Therapy: Data From the SCohoLART Study
Camilla Muccini, Nicola Gianotti, Sara Diotallevi, et al.
Clinical Therapeutics
|
August 25, 2024
Combination of High-Dose Daptomycin and Ceftriaxone for Cardiac Implantable Electronic Device Infections: A 10-Year Experience
Giacomo Ponta, Martina Ranzenigo, Alessandra Marzi, et al.
The Journal of Antimicrobial Chemotherapy
|
February 3, 2012
Viral tropism by geno2pheno as a tool for predicting CD4 decrease in HIV-1-infected naive patients with high CD4 counts
Silvia Nozza, Filippo Canducci, Laura Galli, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 14, 2009
Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis
Antonella d'Arminio Monforte, Alessandro Cozzi-Lepri, Antonella Castagna, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
December 14, 2020
Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Adults With HIV and M184V/I Mutation
Ignacio Perez-Valero, Josep M Llibre, Antonella Castagna, et al.
Plants (Basel, Switzerland)
|
July 27, 2022
Foliar and Root Comparative Metabolomics and Phenolic Profiling of Micro-Tom Tomato (<i>Solanum lycopersicum</i> L.) Plants Associated with a Gene Expression Analysis in Response to Short Daily UV Treatments
Alessia Mannucci, Marco Santin, Lucas Vanhaelewyn, et al.
Plos One
|
August 2, 2017
Efficacy and safety of switching from branded to generic antiretrovirals in virologically suppressed HIV-infected patients
Nicola Gianotti, Andrea Poli, Laura Galli, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
August 16, 2022
Prevalence and Risk Factors of Anal HPV Infection in MSM Living With HIV: Identifying the Target Groups to Prioritize for Immunization
Elena Bruzzesi, Laura Galli, Andrea Poli, et al.
HIV Medicine
|
December 1, 2025
User-reported outcomes of long-acting injectable PrEP with Cabotegravir: Real-world experience from Milan
Angelo Roberto Raccagni, Flavia Passini, Riccardo Lolatto, et al.
Page
of 47